Section Arrow
Quote
AMPH.NASDAQ
- Amphastar Pharmaceuticals
Quotes are at least 15-min delayed:2026/05/13 10:25 EDT
Regular Hours
Last
 18.21
+0.71 (+4.06%)
Day High 
18.37 
Prev. Close
17.5 
1-M High
24.345 
Volume 
142.43K 
Bid
18.19
Ask
18.23
Day Low
17.43 
Open
17.5 
1-M Low
17.26 
Market Cap 
771.63M 
Currency 美元 
P/E 10.98 
%Yield -- 
10-SMA 21.45 
20-SMA 21.59 
50-SMA 20.46 
52-W High 31.2641 
52-W Low 17.03 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.66/--
Enterprise Value
1.42B
Balance Sheet
Book Value Per Share
17.54
Cash Flow
Cash Flow Yield
0.20
Income Statement
Total Revenue
719.89M
Operating Revenue Per Share
13.64
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health23.545-1.485-5.93%-- 
ESPREsperion Therapeutics3.135+0.005+0.16%-- 
ZTSZOETIS75.98-0.96-1.25%12.56PE
HLNHaleon plc9.035-0.065-0.71%18.08PE
BCRXBioCryst Pharmaceuticals9.054+0.254+2.89%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.